The Immunology Program at CSB brings together investigators who conduct basic immunology research to understand complex disease processes. The program focuses on questions that are relevant to human health. Program members work closely within CSB but also maintain strong ties with other investigators at MGH, within the Harvard community, nationally and internationally. Program leaders emphasize the use of in vivo integrative and systems biology approaches as well as state-of-the-art imaging, surgical, genetic, cellular and molecular tools. Currently, major areas of interest include:
Immunology of atherosclerosis: Circulating leukocytes, among them monocytes, are essential to initiation, progression and complications of atherosclerosis. Monocytes are functionally heterogeneous and may play differential roles in disease. This program investigates how monocytes and their progeny contribute to atherosclerosis.
Immunology of myocardial infarction: Myocardial infarction triggers recruitment of diverse immune cell types (neutrophils, monocyte subtypes), which are critical for tissue repair. The program studies the regulation of immune responses to ischemic injury, and new therapeutic targets that can influence healing and post-MI ventricular remodeling.